InterventionsHuman trial

RAY1225, a Biweekly Biased GLP-1/GIP RA for Weight Management: A Phase 2 Trial in Chinese Overweight/Obese Adults (REBUILDING-1)

ADA Scientific Sessions 2026 Abstract

The paper

Linong Ji, Li Yan, Mingtong Xu,

Leili Gao, Xue Xia, Chong Wang, Yongyao Zhu, J Li, Yun Peng, H H Li,

Beijing

ADA Scientific Sessions 2026 Abstract · 7 Jun 2026

Presented at ADA Scientific Sessions 2026 · Oral 1227-OR

doi.org/10.2337/db26-1227-or

A triple-target drug cut body weight by up to 19.7% in a trial
Cell Metabolism · 8 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026